Perrigo fails in bid to block Mylan’s Israeli stock listing

Court rules against Dublin-based pharma company’s attempt to halt Tel Aviv listing

Mylan has said an Israeli district court has ruled against target Perrigo 's attempt to block Mylan's listing on the Tel Aviv Stock Exchange.

A Tel Aviv listing will strengthen Netherlands-based Mylan’s efforts to get Perrigo shareholders on its side.

Dublin-based Perrigo has repeatedly urged its shareholders not to accept Mylan’s $25 billion hostile bid.

Mylan, which first made a bid for Perrigo in April, went hostile in September. Perrigo shareholders have until November 13th to accept the tender offer.

READ MORE

"We are very pleased by the court's ruling, clearing the way for the TASE to approve our listing and for Perrigo's Israeli shareholders to participate in our highly compelling offer," Mylan chairman Robert Coury said.

Mylan had said in June that the company would like to join the Tel Aviv Stock Exchange if it succeeds in buying Perrigo.

Shares of Mylan closed at $44.89 on the Nasdaq on Wednesday.

Reuters